Recruiting Hepatitis B Studies in Palo Alto
About Hepatitis B Clinical Trials in Palo Alto
Hepatitis B is a liver infection caused by the hepatitis B virus that can become chronic and lead to cirrhosis, liver failure, or liver cancer. A vaccine can prevent infection. Treatment for chronic hepatitis B includes antiviral medications that suppress the virus.
There are currently 1 hepatitis b clinical trials recruiting participants in Palo Alto, CA. These studies are seeking a combined 70 participants. Research is being sponsored by AusperBio Therapeutics Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Hepatitis B Clinical Trials in Palo Alto — FAQ
Are there hepatitis b clinical trials in Palo Alto?
Yes, there are 1 hepatitis b clinical trials currently recruiting in Palo Alto, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Palo Alto?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Palo Alto research site will contact you about next steps.
Are clinical trials in Palo Alto free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Palo Alto studies also compensate for your time and travel.
What hepatitis b treatments are being tested?
The 1 active trials in Palo Alto are testing new therapies including novel drugs, biologics, and treatment approaches for hepatitis b.
Data updated October 12, 2026 from ClinicalTrials.gov